Alternatives to Altos Labs

Developing novel therapies to reverse aging and extend lifespan.

Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.

Celljevity pioneers cellular rejuvenation and AI-driven health optimization to reverse biological aging.

Buy Now, Pay Later (BNPL) service offering flexible payment options at checkout.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

Developing epigenetic reprogramming drugs for age restoration.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Developing AI-powered solutions for drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).